Company found to have overcharged for older-generation cancer drugs in Italy
Major South African generic drug manufacturer Aspen Pharmacare has been fined ß5-million (R76.4-million) by Italian competition authorities for pushing the prices of older-generation blood cancer drugs sky-high, potentially disrupting their supply.
Aspen, which has extensive operations in Port Elizabeth, started manufacturing generic medication in South Africa and now manufactures or supplies medicines in 150 countries.
